Pam Garside, who has stepped down as Chair of the Cambridge Angels investment group, is confident that the organisation will continue to be a dynamic force for UK corporate growth. The healthcare ...

Cambridge Vacuum Engineering (CVE) and Ford have successfully completed a £430,000 Innovate UK-funded EB-eDrive project – proving that the manufacture of electric motor stators can be improved by ...

Cambridge-based breath biopsy trailblazer Owlstone Medical is partnering three influential US organisations in a multimillion dollar campaign to detect and eliminate cancer before the disease takes ...

Deloitte has welcomed 1,400 new people to its award-winning graduate, BrightStart apprenticeship and industrial placement programmes in 17 locations across the UK. This includes 32 new starters in ...

Hewitsons' history traces back to a legal practice founded in Northampton in 1844 by John and Henry Becke, though the firm's name came from Roy Barker Hewitson who joined a Cambridge practice (A.H.

More than 50 firms in East Anglia are ranked in the new 2026 Legal 500 Guide, with just over 300 rankings awarded across all practice areas and tiers.

Despite a worldwide boom in the use of artificial intelligence, many UK companies remain hesitant to invest in it, writes Bernd Storm van’s Gravesande, co-founder and Managing Director of Bits & ...

Trials are underway to test the viability of electric air taxi operations between Cambridge and Oxford. The venture could prove a crucial cog in plans to expand the trade corridor as the Government ...

The UK Space Agency has awarded grant funding (amount unspecified) to Cambridge startup LinkGevity,to determine whether its anti-ageing solution could work away from Earth.

NoBACZ Healthcare, a University of Cambridge spin-out developing novel products that change the way lesions and wounds are ...

Nxera Pharma in Cambridge and Japan has reached a second important R & D milestone under its multi-target discovery collaboration with North Chicago company AbbVie focused on neurological diseases, ...

Cambridge headquartered life science giant AstraZeneca saw its UK share price rocket 86p and market cap rise to £1781.5 billion as it today confirmed plans for a dual UK-US Stockmarket listing. Michel ...